The MRC's CEO Award Scheme recognises contributions from employees for outstanding effort and commitment to both their work and the MRC as an organisation.
In their papers published in Cell Metabolism members of Professor Massimo Zeviani's group, and that of Luca Scorrano at the University of Padua have identified a potential therapeutic target for combating mitochondrial disease.
Figure | Overall map for complex I from B. taurus heart mitochondria determined by single-particle cryo-EM.
On Wednesday, 5 June 2013, Professor Massimo Zeviani will be presented with the 2013 Grand Prix of the NRJ Foundation, on "Genetics of degenerative diseases", under the cupola of the Institute of France. The award is made to support Professor Zeviani’s work on the genetics of mitochondrial diseases. "The Prize of the NRJ Foundation will allow me to continue my research which aims at understanding why mitochondrial deficiency leads to brain damage and how to correct or even halt the progression of disease in patients." - Massimo Zeviani
After fifteen years as Director of this Unit, John Walker has stepped down from this role. Known originally as the MRC Dunn Human Nutrition Unit, it was renamed the MRC Mitochondrial Biology Unit in 2009. John will continue to pursue his research interests at the MBU.
